Get the Stockscreener App
1.64
3.53%
-0.06
Aptevo Therapeutics Inc stock is traded at $1.64, with a volume of 102.87K.
It is down -3.53% in the last 24 hours and down -42.66% over the past month.
Aptevo Therapeutics Inc is a clinical-stage research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidates are; ALG.APV-527, which targets co-stimulatory receptors and tumor antigens, and CD3xCD123, which is being developed as a potential treatment of frontline acute myelogenous leukemia. The company's preclinical candidates, APVO711, APVO0442, and APVO603, are being developed using the ADAPTIR modular protein technology platform. The company's versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.
See More
Previous Close:
$1.70
Open:
$1.72
24h Volume:
102.87K
Relative Volume:
0.05
Market Cap:
$5.39M
Revenue:
$12.99M
Net Income/Loss:
$-23.72M
P/E Ratio:
-0.0169
EPS:
-97.2514
Net Cash Flow:
$-23.28M
1W Performance:
-17.17%
1M Performance:
-42.66%
6M Performance:
-97.72%
1Y Performance:
-99.37%
1-Day Range:
$1.6105
$1.72
1-Week Range:
$1.6105
$2.05
52-Week Range:
$1.6105
$381.10
Aptevo Therapeutics Inc Stock (APVO) Company Profile
Name
Aptevo Therapeutics Inc
Sector
Industry
Phone
206-838-0500
Address
2401 4TH AVE., SEATTLE, WA
Compare APVO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
APVO
Aptevo Therapeutics Inc
|
1.64 | 5.59M | 12.99M | -23.72M | -23.28M | -97.25 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Aptevo Therapeutics Inc Stock (APVO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-05-18 | Initiated | Ladenburg Thalmann | Buy |
| Oct-05-17 | Resumed | Piper Jaffray | Overweight |
Aptevo Therapeutics Inc Stock (APVO) Latest News
Historical volatility pattern of Aptevo Therapeutics Inc. visualizedJuly 2025 Institutional & High Conviction Buy Zone Picks - Newser
Ranking Aptevo Therapeutics Inc. among high performing stocks via toolsIPO Watch & Free Fast Entry Momentum Trade Alerts - Newser
Will breakout in Aptevo Therapeutics Inc. lead to full recoveryJuly 2025 Fed Impact & Fast Entry High Yield Stock Tips - Newser
How institutional ownership impacts Aptevo Therapeutics Inc. stockWeekly Trade Report & Weekly Breakout Opportunity Watchlist - Newser
Can technical indicators confirm Aptevo Therapeutics Inc.’s reversalBull Run & Consistent Return Strategy Ideas - Newser
Can volume confirm reversal in Aptevo Therapeutics Inc.July 2025 Highlights & Verified Short-Term Plans - Newser
Why Aptevo Therapeutics Inc. is moving todayMarket Trend Review & Safe Swing Trade Setup Alerts - Newser
Custom watchlist performance reports with Aptevo Therapeutics Inc.July 2025 Selloffs & Short-Term High Return Ideas - Newser
Can momentum traders help lift Aptevo Therapeutics Inc.Earnings Miss & Consistent Growth Stock Picks - Newser
Published on: 2025-08-31 00:36:04 - Newser
Real time pattern detection on Aptevo Therapeutics Inc. stockGap Down & High Conviction Buy Zone Picks - Newser
Risk vs reward if holding onto Aptevo Therapeutics Inc.2025 Earnings Surprises & Real-Time Volume Trigger Notifications - Newser
How to manage a losing position in Aptevo Therapeutics Inc.July 2025 Institutional & Real-Time Stock Movement Alerts - Newser
Real time social sentiment graph for Aptevo Therapeutics Inc.Insider Buying & Reliable Breakout Forecasts - Newser
Using Python tools to backtest Aptevo Therapeutics Inc. strategies2025 Market Outlook & Daily Technical Stock Forecast Reports - Newser
News impact scoring models applied to Aptevo Therapeutics Inc.Weekly Trade Recap & Fast Moving Market Watchlists - Newser
Using Bollinger Bands to evaluate Aptevo Therapeutics Inc.Insider Buying & Long Hold Capital Preservation Plans - Newser
How liquid is Aptevo Therapeutics Inc. stockWeekly Stock Analysis & Long-Term Growth Plans - sundaytimes.kr
Will a bounce in Aptevo Therapeutics Inc. offer an exitMarket Performance Report & Precise Buy Zone Tips - Newser
Applying chart zones and confluence areas to Aptevo Therapeutics Inc.2025 AllTime Highs & Intraday High Probability Alerts - Newser
Aptevo Therapeutics Inc Stock (APVO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.96%
1.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):